We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Biogen Inc | NASDAQ:BIIB | NASDAQ | Common Stock |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
214.00 | 217.25 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 9.84B | 1.16B | 7.9877 | 26.98 | 31.33B |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
12:16:18 | 1 | 215.50 | USD |
Date | Time | Source | Headline |
---|---|---|---|
29/9/2023 | 21:49 | DJN | Biogen's Tofidence Intravenous Formulation Gets FDA Approval |
07/8/2023 | 13:18 | DJN | Sage Therapeutics Shares Slide Premarket After Zurzuvae MDD Setback |
07/7/2023 | 05:39 | DJN | Trending: Eisai, Biogen's Alzheimer's Treatment Gets Full FDA Approval |
Biogen (BIIB) Share Charts1 Year Biogen Chart |
|
1 Month Biogen Chart |
Intraday Biogen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions